Vasopressin in septic shock [1]

New England Journal of Medicine

Volumn 358, Issue 25, 2008, Pages 2736-2738

  Boyle, Walter A ^a   Leone, Marc ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; CATECHOLAMINE;

DISEASE SEVERITY; HUMAN; LETTER; LOW DRUG DOSE; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL; DRUG COMBINATION; NOTE; HOSPITALIZATION; TREATMENT OUTCOME; CLINICAL RESEARCH; DRUG EFFICACY;

DRUG THERAPY, COMBINATION; HUMANS; NOREPINEPHRINE; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 45549099366     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080666     Document Type: Letter

References (3)

1. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.
2. Parrillo JE. Septic shock - vasopressin, norepinephrine, and urgency. N Engl J Med 2008;358:954-6.
3. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med 2006;34:1126-30.